Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry
- PMID:18922655
- DOI: 10.1016/j.forsciint.2008.09.001
Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry
Abstract
Studies on the metabolism and the toxicological detection of the phencyclidine-derived designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine are described using gas chromatographic-mass spectrometric (GC-MS) techniques. Based on the identified metabolites, the following metabolic pathways could be postulated: N-dealkylation, O-demethylation partially followed by oxidation of the resulting alcohol to the corresponding carboxylic acid, hydroxylation of the cyclohexyl ring at different positions, and aromatic hydroxylation. The formed metabolites were identical to those of the homologue N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA) with exception of the mono hydroxyl metabolites of PCEPA. All PCMPA metabolites were partially excreted in conjugated form. An intake of a common drug users' dose of PCMPA could be detected in rat urine by the authors' systematic toxicological analysis (STA) procedure using full-scan GC-MS after acid hydrolysis, liquid-liquid extraction and microwave-assisted acetylation. The STA should be suitable for proof of an intake of PCMPA also in human urine assuming similar metabolism.
Similar articles
- New designer drug N-(1-phenylcyclohexyl)-3-ethoxypropanamine (PCEPA): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH.Sauer C, et al.J Mass Spectrom. 2006 Aug;41(8):1014-29. doi: 10.1002/jms.1058.J Mass Spectrom. 2006.PMID:16817170
- New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques.Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH.Sauer C, et al.J Mass Spectrom. 2008 Mar;43(3):305-16. doi: 10.1002/jms.1312.J Mass Spectrom. 2008.PMID:17968862
- Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry.Sauer C, Peters FT, Staack RF, Fritschi G, Maurer HH.Sauer C, et al.J Chromatogr A. 2008 Apr 4;1186(1-2):380-90. doi: 10.1016/j.chroma.2007.11.002. Epub 2007 Nov 5.J Chromatogr A. 2008.PMID:18035363
- Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.Maurer HH.Maurer HH.J Mass Spectrom. 2006 Nov;41(11):1399-413. doi: 10.1002/jms.1112.J Mass Spectrom. 2006.PMID:17051522Review.
- Metabolism of designer drugs of abuse: an updated review.Meyer MR, Maurer HH.Meyer MR, et al.Curr Drug Metab. 2010 Jun 1;11(5):468-82. doi: 10.2174/138920010791526042.Curr Drug Metab. 2010.PMID:20540700Review.
Cited by
- New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".A Michely JA, Manier SK, Caspar AT, Brandt SD, Wallach J, Maurer HH.A Michely JA, et al.Curr Neuropharmacol. 2017;15(5):692-712. doi: 10.2174/1570159X14666161018151716.Curr Neuropharmacol. 2017.PMID:27758707Free PMC article.
- Microwave-assisted derivatization procedures for gas chromatography/mass spectrometry analysis.Söderholm SL, Damm M, Kappe CO.Söderholm SL, et al.Mol Divers. 2010 Nov;14(4):869-88. doi: 10.1007/s11030-010-9242-9. Epub 2010 Mar 12.Mol Divers. 2010.PMID:20225067Review.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Miscellaneous